Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

General Information

Ansell Limited
ANN
http://www.ansell.com
Health Care Supplies
4,089
153

Current Price Data+

Current Price Open High Low Last Close Volume Price Movement
$26.70 $27.00 $27.00 $26.61 $26.80 431169 $0.10 ( 0.37% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Current Broker Consensus Recommendation

Hold
21/05/2015
3

Company Overview

Business Description
Ansell Limited (ANN) is a global provider of health and safety protection solutions. ANN designs, develops, manufactures and distributes a range of surgical, examination, industrial and household gloves, protective clothing and condoms. Currently, ANN operates four main business divisions which are medical, industrial, single use and sexual wellness.
Strategy Analysis
ANN is focused on developing new and innovative products, new distribution channels and growing market share. Cost cutting, manufacturing rationalisations, and shifting its portfolio of products towards higher margin items aim to offset input cost pressures. ANN is shifting away from producing commoditised products with no pricing power to producing patentable products which avoid the commodity trap. Revenue growth is typically modest, in response ANN looks for new emerging markets, such as China and Eastern Europe for sales. ANN is also mindful of the necessity to invest in research and development in order to develop more patentable products, such as the highly successful Hyflex range. Ansell reported NPAT down 15.3% to $55.0m for the half-year ended 31 December 2012. Revenues from ordinary activities were $627.9m, up 5.1% from the same period last year. Diluted EPS was 41.8 cents compared to 49.2 cents last year. The net operating cash inflow was $44.8m compared to an outflow of $16.7m in the pcp. The interim dividend declared was 16 cents compared with 15 cents last year.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2016 F 265.5 173.6 12.1% 15.4 63.2 2.4% 0.0%
2015 F 236.8 154.8 40.6% 17.2 55.8 2.1% 0.0%
2014 A 157.1 110.1 3.8% 17.5 39.0 2.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2014 A 2015 F 2016 F 2014 A 2015 F 2016 F 2014 A 2015 F 2016 F
Ansell (ANN) $4,104M 0.1120 0.3444 0.1144 23.1274 17.2026 15.4360 1.54% 2.08% 2.40%
Nanosonics (NAN) $532M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.62 17.50 3.42 0.78
Market 0.99 17.00 1.32 1.59
Sector 0.68 23.50 2.81 1.23

Directors

Name Position Start Date
Mr Magnus Ranae Nicolin Chief Executive Officer, Managing Director 01/03/2010
Mr William Peter Day Non-Executive Director 20/08/2007
Mr Ronald J Bell Non-Executive Director 09/08/2005
Mr L (Dale) Crandall Non-Executive Director 11/10/2002
Ms Marissa T Peterson Non-Executive Director 22/08/2006
Mr John Andrew Bevan Non-Executive Director 01/08/2012
Mrs Annie Lo Non-Executive Director 01/01/2013
Mr Glenn Lawrence Lord Barnes Non-Executive Director, Non-Executive Chairman 12/09/2005

Management

Name Position
Alistair Grant Associate General Counsel Asia Pacific,Company Secretary
Peter Dobbelsteijn Chief Commercial Officer EMEA and APAC region and Ansell Global Guardian
Mike Mattos Chief Commercial Officer North America region
Scott R Corriveau President Industrial GBU
Anthony Lopez President Medical GBU and Chief Commercial Officer LAC region
Joe Kubicek President Single Use GBU
Neil Salmon Senior Vice President and Chief Financial Offer
Steve Genzer Senior Vice President Global Supply Chain Operations
William Reilly Senior Vice President, Corporate General Counsel,Company Secretary

Substantial Shareholders

Holding Name
23,973,737 (18.01%) M&G Group
12,929,626 (9.89%) Lazard Asset Management Pacific Co
9,450,104 (7.23%) Matthews International Capital Management LLC
9,340,208 (7.15%) FMR LLC and FIL (formerly FMR Corp and FIL)

Calendar of Events

Date Event
08 February 2016 Report (Interim)
11 September 2015 Report (Annual)
17 August 2015 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.